First Page | Document Content | |
---|---|---|
![]() Date: 2015-06-19 09:17:30Monoclonal antibodies Immunosuppressants Immunology Biotechnology Immune system Adalimumab Tocilizumab Infliximab Monoclonal antibody therapy Disease-modifying antirheumatic drug TNF inhibitor Rheumatology | Add to Reading List |
![]() | EAP Reimbursement Criteria for Frequently Requested DrugsDocID: 1rhhE - View Document |
![]() | TABLE OF CONTENTS INTRODUCTION 2DocID: 1qY7G - View Document |
![]() | JUNE 2015 TABLE OF CONTENTS INTRODUCTIONDocID: 1qDC6 - View Document |
![]() | Provincial Drug Programs P. O. Box 2000 Charlottetown PE C1A 7N8Toll Free on PEI) Programmes provinciaux de médicamentsDocID: 1qAvE - View Document |
![]() | TABLE OF CONTENTS INTRODUCTION 2DocID: 1qs3R - View Document |